Avidity Biosciences Inc

Change company Symbol lookup

Select an option...

RNA Avidity Biosciences Inc

AVA Avista Corp

DKNG DraftKings Inc

ADXN Addex Therapeutics Ltd

SSU SIGNA Sports United NV

RVIV Reviv3 Procare Co

BJDX Bluejay Diagnostics Inc

SHYMF Nala Digital Commerce Ltd

PM Philip Morris International Inc

EPAC Enerpac Tool Group Corp

Go

Avidity Biosciences, Inc. is a biopharmaceutical company. The Company is engaged in delivering a new class of ribonucleic acid (RNA) therapeutics called antibody oligonucleotide conjugates (AOCs.). The Company's AOC platform is designed to combine the specificity of monoclonal antibodies (mAbs), with the precision of RNA therapeutics to target the root cause of diseases previously untreatable with RNA therapeutics. The AOC platform also has the option to deploy various types of oligonucleotides, including small interfering RNA (siRNAs) and patient measure of safety (PMOs), whose specific mechanisms of action modify RNA function in different ways. The Company's pipeline includes AOC 1001, and AOC 1020. AOC 1001 is designed to treat people with myotonic dystrophy type 1 (DM1). AOC 1020 is designed to treat people living with facioscapulohumeral.